Elon Musk’s Neuralink says has FDA approval for study of brain implants in humans
May 25 (Reuters) - Elon Musk's brain-implant company Neuralink on Thursday said the U.S. Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles…
